Century Therapeutics, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, loss from operations were $23,021,000 against $15,516,000 a year ago. Net loss was $23,273,000 against $15,301,000 a year ago. Comprehensive loss was $23,250,000 against $15,204,000 a year ago.
For the six months, loss from operations were $41,083,000 against $25,509,000 a year ago. Net loss was $41,621,000 against $24,974,000 a year ago. Comprehensive loss was $41,621,000 against $24,850,000 a year ago.